Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/144.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) > Binds receptor > Receptor integral to or derived from a lymphocytic or lymphocytic-like cell (e.g., nk cell, etc.)
Description: Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a receptor integral to or derived from a lymphocytic or a lymphocytic-like cell.

Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13

Patent Number Title Of Patent Date Issued
5424066 Method for increasing CD4+ cell numbers through the use of monoclonal antibodies directed against self-reactive, CD4 specific cytotoxic T-cells Jun. 13, 1995
5336489 Treatment of allograft rejection with IL-2 receptor-specific cytotoxins Aug. 9, 1994
5326559 Treatment of accelerated atheosclerosis with interleukin-2 receptor targeted molecules Jul. 5, 1994
5316763 Short-term anti-CD3 stimulation of lymphocytes to increase their in vivo acitivity May. 31, 1994
5273743 Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent Dec. 28, 1993
5223426 Monoclonal antibodies reactive with defined regions of the T-cell antigen receptor Jun. 29, 1993
5152980 Induction of tolerance to a foreign antigen IL-2 receptor-binding substances Oct. 6, 1992
5084391 Monoclonal antibody to the interleukin-2-receptor and its use Jan. 28, 1992
5078998 Hybrid ligand directed to activation of cytotoxic effector T lymphocytes and target associated antigen Jan. 7, 1992
5028424 Antibodies to receptor and antigen for natural killer and non-specific cytotoxic cells Jul. 2, 1991
5011684 Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance Apr. 30, 1991
4908203 Method for inducing HIV neutralizing antibodies using an internal image idiotope Mar. 13, 1990
4786590 Diagnostic and therapeutic aspects of receptor-mediated leukemogenesis Nov. 22, 1988
4676980 Target specific cross-linked heteroantibodies Jun. 30, 1987
4434156 Monoclonal antibodies specific for the human transferrin receptor glycoprotein Feb. 28, 1984

1 2 3 4 5 6 7 8 9 10 11 12 13

  Recently Added Patents
Cell surface display, screening and production of proteins of interest
Obviation of recovery of data store consistency for application I/O errors
Methods and arrangements for realising betting with off-line terminal
Method of providing user-tailored entertainment experience at hospitality location and hospitality media system thereof
Direct connect single layer touch panel
Display screen or portion thereof with graphical user interface
Heterogeneous language data typing without executable regeneration
  Randomly Featured Patents
Semiconductor module and method for fabricating semiconductor module
Crystalline (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-3,4-dihydro-2(1H)-quin azolinone
Method and system for providing audio-only recording of an audio/video signal
Polymerizable radiopaque dental composition
Instrument for compression or distraction
Wall mounted modular tray
Fabric turner
Cytotoxic compounds
Coupler-based optical cross-connect having a regeneration module
Tin-plated film and method for producing the same